ANPAC BIO-MEDICAL SCIENCE

anpac-bio-medical-science-logo

Anpac Bio-Medical Science Company, Ltd., is led by award-winning and internationally respected biomedical and nanotechnology scientists, medical professionals, and engineering experts -- creating and launching break-through, leading-edge, early cancer screening, detection, and diagnostic technology. Known as Anpac's "Cancer Differentiation Analysis" (CDA) program, Anpac's innovative and proprietary CDA medical devices measure “Blood Biopsies” -- effectively and dramatically-improving cancer ... detection sensitivity, and specificity, without producing any side-effects in patients. As demonstrated and confirmed in over 22,000 cases to date, Anpac’s CDA diagnostics can detect and identify early signals of threatening cancer – and the type of cancer (location in the body) – often before the threat becomes or grows into tumors.

#SimilarOrganizations #People #Financial #Event #Website #More

ANPAC BIO-MEDICAL SCIENCE

Social Links:

Industry:
Biotechnology Medical Nanotechnology

Founded:
2008-01-01

Address:
Shanghai, Shanghai, China

Country:
China

Website Url:
http://www.anpacbio.com

Total Employee:
101+

Status:
Active

Contact:
(314)326-7292

Total Funding:
35.65 M USD

Technology used in webpage:
Euro IPv6 Akamai Hosted


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

mabspace-biosciences-logo

MabSpace Biosciences

MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.

new-horizon-health-logo

New Horizon Health

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

not_available_image

Ruifu Biological Medicine Science and Technology (Shanghai)

Ruifu Biological Medicine Science and Technology is a biotechnology company focused on the R&D of pharmaceutical products.

Current Employees Featured

herbert-yu_image

Herbert Yu
Herbert Yu Co-Founder & Chief Science Officer @ AnPac Bio-Medical Science
Co-Founder & Chief Science Officer

drisha-leggitt_image

Drisha Leggitt
Drisha Leggitt Vice President, Business Development @ AnPac Bio-Medical Science
Vice President, Business Development

chris-yu_image

Chris Yu
Chris Yu Founder & CEO @ AnPac Bio-Medical Science
Founder & CEO

Founder


chris-yu_image

Chris Yu

herbert-yu_image

Herbert Yu

Stock Details


Company's stock symbol is NASDAQ:ANPC

Investors List

keystone-capital-partners_image

Keystone Capital Partners

Keystone Capital Partners investment in Post-IPO Equity - AnPac Bio-Medical Science

zhangjiang-science-technology-investment-corporation_image

Zhangjiang Science & Technology Investment Corporation

Zhangjiang Science & Technology Investment Corporation investment in Series B - AnPac Bio-Medical Science

zhangjiang-science-technology-investment-corporation_image

Zhangjiang Science & Technology Investment Corporation

Zhangjiang Science & Technology Investment Corporation investment in Series A - AnPac Bio-Medical Science

yingta-jiankang-guanli_image

Yingta Jiankang Guanli

Yingta Jiankang Guanli investment in Angel Round - AnPac Bio-Medical Science

Official Site Inspections

http://www.anpacbio.com Semrush global rank: 5.61 M Semrush visits lastest month: 1.51 K

  • Host name: any-in-2215.1e100.net
  • IP address: 216.239.34.21
  • Location: Mexico City Mexico
  • Latitude: 19.3421
  • Longitude: -99.1927
  • Timezone: America/Mexico_City
  • Postal: 01090

Loading ...

More informations about "AnPac Bio-Medical Science"

Home – ANPAC

ANPAC Founded in 2010 by interdisciplinary scientists and expert returnees in the fields of medicine, physics, biochemistry, etc., ANPAC is considered as one of the pioneers and main leaders of multi(pan)-cancer detection and multi-dimensional multi-parameter cancer …See details»

AnPac Bio-Medical Science - Crunchbase Company …

Anpac Bio-Medical Science is a biotechnology company that focuses on early cancer screening and detection. A variety of cancer screening and detection tests are carried out by AnPac Bio, including tests for biochemistry, immunology, …See details»

Anpac Bio Technology, USA | LinkedIn

Anpac Bio Technology, USA | 669 followers on LinkedIn. The best way to beat cancer is to catch it early! | Anpac Bio-Medical Science Company, Ltd., is led by award-winning and internationally ...See details»

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives …

Sep 22, 2021 For more information, visit the company’s website at www.AnPacBio.com. ... As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide …See details»

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC

Aug 17, 2021 According to the World Health Organization (“WHO”), there were 135 million cancer patients globally in 2020, with 32 million geographically located in China. The new figures mark a 20 million increase in the number of worldwide cases, 4.7 million of which in China. ...See details»

AnPac Bio-Medical Science - Overview, News & Similar ... - ZoomInfo

Apr 2, 2023 AnPac Bio-Medical Science contact info: Phone number: +86 5782051666 Website: www.anpacbio.com What does AnPac Bio-Medical Science do? AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 150 issued patents as of …See details»

AnPac Bio-Medical Science Co. Ltd. to Begin Proposed Public

Nov 10, 2021 For more information about the company, visit www.AnPacBio.com. ... As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best ...See details»

Anpac Bio-Medical Science - Craft

Anpac Bio-Medical Science has 1 employees across 4 locations and ¥12.04 m in annual revenue in FY 2022. See insights on Anpac Bio-Medical Science including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

AnPac Bio-Medical Science Announces Signing of US$5.2 Million …

New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China ...See details»

AnPac Bio Announces Appointment of New Directors and

Aug 5, 2022 Email: phil_case@AnPacbio.com. Investor Relations: Ascent Investor Relations LLC Tina Xiao, President Phone: +1-917-609-0333 (US) Email: ...See details»

Anpac Bio Completes Over 200,000 Biophysics Based Cancer …

Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer. San Jose, CA, October 26, 2020 – Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company …See details»

AnPac Bio Files CDA Device for Breakthrough Medical Device

Feb 3, 2022 --AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced today that it has filed for ...See details»

AnPac Bio’s First Disease Treatment Patent Granted, and Its

Jun 18, 2021 For more information, please visit: https://www.Anpacbio.com. For investor and media inquiries, please contact: Company: Phil Case, Marketing and Investor Relations Phone: +1-267-810-6776 (US)See details»

AnPac Bio Reports Fiscal Year 2021 Annual Financial Results

Total revenues were RMB18.0 million (US$2.8 million) in fiscal year 2021, a decrease of 12.3% from RMB20.5 million (US$3.1 million) in fiscal year 2020.See details»

AnPac Bio Class III Medical Device Passes Extensive NMPA …

PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based biotechnology company focused on ...See details»

AnPac Bio Successfully Completes Major PreClinical Study,

Aug 23, 2021 For more information, please visit: https://www.Anpacbio.com. For investor and media inquiries, please contact: Company: Phil Case, Marketing and Investor Relations Phone: +1-267-810-6776 (US)See details»

AnPac Bio and Roche Pharmaceuticals China Entered into

Aug 5, 2021 According to data from World Health Organization (WHO), there were 135 million global cancer patients in 2020, of which 32 million were from China. ... Email: phil_case@AnPacbio.com. Investor ...See details»

AnPac Bio and Roche Pharmaceuticals China Entered into …

According to data from World Health Organization (WHO), there were 135 million global cancer patients in 2020, of which 32 million were from China. Global cancer patients increased 20 million ...See details»

AnPac Bio Granted a New US patent on Novel Medical Device for …

Feb 1, 2021 For investor and media inquiries, please contact: Company:Phil Case, Marketing and Investor RelationsPhone: +1-267-810-6776 (U.S.)Email: phil_case@AnPacbio.com Investor Relations:Ascent Investor ...See details»

linkstock.net © 2022. All rights reserved